PMID: 71525Oct 1, 1977Paper

Polymorphic hydroxylation of debrisoquine

Lancet
G T TuckerA J Smith

Abstract

No abstract listed.

Citations

Jan 1, 1995·European Journal of Clinical Pharmacology·P K KunickiM Radziwoń-Zaleska
Jan 1, 1990·European Journal of Clinical Pharmacology·I Walter-SackN Zöllner
Jan 1, 1991·European Journal of Clinical Pharmacology·M E Veronese, S McLean
Apr 1, 1985·Klinische Wochenschrift·M S Lennard
Mar 1, 1991·Breast Cancer Research and Treatment·J HuoberD Schmähl
Jan 1, 1989·International Ophthalmology·L SalminenE Iisalo
Jan 1, 1989·Pharmacology & Therapeutics·M S Lennard
Aug 15, 2002·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J L C M DorneA G Renwick
Feb 20, 2002·British Journal of Clinical Pharmacology·Leif BertilssonAyman Al-Shurbaji
Dec 16, 1982·The New England Journal of Medicine·M S LennardH F Woods
May 1, 1992·British Journal of Clinical Pharmacology·J C BloomerG T Tucker
Oct 1, 1990·Pharmacology & Toxicology·M S Lennard
Jan 1, 1986·CRC Critical Reviews in Biochemistry·M Adesnik, M Atchison
Dec 13, 2016·Pharmaceutical Research·Geoffrey T Tucker
Apr 7, 2000·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·T LightfootG T Tucker
Jan 16, 1999·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·G SmithC R Wolf
Oct 24, 2003·International Ophthalmology Clinics·Emily C Greenlee, Young H Kwon
Nov 18, 2005·Journal of Clinical Pharmacology·Paula Macedo CerqueiraVera Lucia Lanchote
May 20, 1998·Clinical Pharmacology and Therapeutics·P DalénL Bertilsson
Mar 1, 1991·Acta Neurologica Scandinavica·J KallioE Syvälahti
Mar 1, 1995·Canadian Journal of Physiology and Pharmacology·T InabaG T Tucker
Apr 1, 1988·British Journal of Clinical Pharmacology·M EichelbaumC O Meese
Jan 1, 1984·Critical Reviews in Toxicology·B Clark, D A Smith
Apr 1, 1980·British Journal of Clinical Pharmacology·J H SilasN R Fieller
Dec 1, 1988·British Journal of Clinical Pharmacology·J KallioE Iisalo
Nov 1, 1986·British Journal of Clinical Pharmacology·P R JacksonH F Woods
Feb 1, 1987·Journal of Clinical Pharmacology·J R WoodworthK S Rotenberg
Jan 1, 1984·British Journal of Clinical Pharmacology·J H SilasH F Woods
May 1, 1982·British Journal of Clinical Pharmacology·G C KahnD S Davies
Jan 1, 1981·British Journal of Clinical Pharmacology·D S DaviesA R Boobis
Aug 25, 2020·Toxicological Research·F Peter Guengerich
Aug 1, 1982·British Journal of Clinical Pharmacology·M S LennardJ Trevethick
Dec 1, 1985·British Journal of Clinical Pharmacology·J C McGourtyH F Woods
Mar 1, 2012·British Journal of Clinical Pharmacology·Geoffrey T Tucker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.